Atossa Therapeutics
ATOS
#9946
Rank
NZ$80.89 M
Marketcap
NZ$9.39
Share price
4.99%
Change (1 day)
687.78%
Change (1 year)

Atossa Therapeutics (ATOS) - Net assets

Net assets on the balance sheet as of September 2025 : NZ$87.17 Million

According to Atossa Therapeutics's latest financial reports the company has NZ$87.17 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Atossa Therapeutics - Net assets on balance sheet (from 2010 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$NZ$0.12 B-11.94%
2023-12-31$NZ$0.14 B-22.54%
2022-12-31$NZ$0.18 B-8.13%
2021-12-31$NZ$0.20 B437.11%
2020-12-31$NZ$37.65 M92.75%
2019-12-31$NZ$19.53 M48.81%
2018-12-31$NZ$13.12 M34.36%
2017-12-31$NZ$9.77 M118.51%
2016-12-31$NZ$4.47 M-18.22%
2015-12-31$NZ$5.46 M-54.9%
2014-12-31$NZ$12.12 M-6.04%
2013-12-31$NZ$12.9 M105.06%
2012-12-31$NZ$6.29 M214.81%
2011-12-31$NZ$1.99 M-280.99%
2010-12-31$-NZ$1.11 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
NZ$142.77 B 163,685.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$12.75 B 14,534.34%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$15.12 B 17,247.30%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ$1.46 B 1,580.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
NZ$75.98 M-12.83%๐Ÿ‡บ๐Ÿ‡ธ USA